[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:gastrointestinal-symptom":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":48,"states":49},"Gastrointestinal symptom",6,2,[8,15,21,28,35,41],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT07421596","An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System",[],"RECRUITING","2026-08-26T02:18:02.701182Z","2026-05-05T02:43:29.350839Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07388264","Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes",[],"2026-08-26T02:18:08.005333Z","2026-05-05T02:43:27.256160Z",{"nct_id":22,"title":23,"phases":24,"status":25,"updated_at":26,"content_modified":27},"NCT06278311","Correlation of Toxins With Gastrointestinal (GI) and Overall Health",[],"NOT_YET_RECRUITING","2026-08-26T02:19:31.671303Z","2026-05-13T02:55:06.430389Z",{"nct_id":29,"title":30,"phases":31,"status":32,"updated_at":33,"content_modified":34},"NCT07471490","Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:57.705506Z","2026-06-16T05:54:07.885105Z",{"nct_id":36,"title":37,"phases":38,"status":32,"updated_at":39,"content_modified":40},"NCT07336615","A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals",[],"2026-08-03T02:18:08.864489Z","2026-06-16T05:54:07.880650Z",{"nct_id":42,"title":43,"phases":44,"status":45,"updated_at":46,"content_modified":47},"NCT06834984","Ritual Synbiotic+, a Dietary Supplement Designed to Impact Gastrointestinal Health, Mood, and Behavior in Women",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:49:02.032053Z","2026-05-05T02:35:31.718709Z",[],[50],{"state":51,"count":52,"slug":53},"California",3,"california"]